Globalisation on pause? How scaleups can navigate today's uncertainty9:30 am - 10:30 am
Caristo was founded in 2018 by Cardiologists at the University of Oxford, following a decade of scientific research and technical development, and is now a leader in supporting the transformation of healthcare from treatment-based medicine to prevention. Caristo’s technology aims to revolutionise diagnosis and treatment, enabling physicians to identify patients with the highest heart attack risk and prescribe effective, personalised treatments that can prevent a fatal heart attack.
To date the company has raised a total of £10.2 million, they recently closed a successful investment round led by BGF and existing investors including Oxford Sciences Innovation (OSI), Longwall Ventures and the Oxford Technology & Innovation Fund (OTIF).
New products in the pipeline will also be capable of predicting stroke and diabetes risk, years in advance.
Business funding insights
A post-exit perspective—with Leigh Howarth, CEO of STATS Group
In August, we announced the successful exit of our investment in STATS Group, an Aberdeen-based pipeline technology specialist for the global energy…
How BGF is helping companies to expand internationally: Elvie & OSL
BGF can support your business to expand overseas, just as we did with fast-growing femtech company Elvie and counter-drone tech business OSL. Read the case studies to learn more.